Table 1. The 5th SGOG-KGOG Joint Meeting.

Date and place	Attendee	Agenda
June 18, 2016, Shanghai, China	SGOG member: Rongyu Zang, Jianqing Zhu, Xiaojun Chen, Xi-Peng Wang, Wen Gao, He Huang, Wei Zhang, Huaying Wang, Li Hua Qiu, Zi-Yong Xiang, Boer Shan, Bing-Yi Yang, Ting-Yan Shi, Rong Jiang, Yuting Luan KGOG member: Byoung-Gie Kim, Jae-Weon Kim, Sang-Yoon Park, Yong-Man Kim, Taek Sang Lee, Kidong Kim, Jeong-Yeol Park*, Hee-Seung Kim*, Dong Hoon Suh*, Jongsoon Kim, Miram Jang, Minseo Kim, Myung-Hee Nam, Seungmee Lee*, Misun Kim*, Jin Young Choi*, E Sun Paik*, Minhee Shim*, Ha Kyun Chang*, Youngjae Lee*, Jung Yeon Park*	SGOG SUNNY trial (Rong Jiang) Prediction of response to neoadjuvant chemotherapy by PET-CT in advanced-stage ovarian cancer (Ha Kyun Chang) Predict lymph node metastasis in endometrial cancer by PR, Ki67, and cancer, SGOG (Xiaojun Chen) Prospective study evaluating a strategy of surgery alone and surveillance in FIGO stage I malignant ovarian germ cell tumor (KGOG 3033) (Jeong-Yeol Park) SGOG SUNNY cooperation: contract including the authorship (Rongyu Zang, Byoung-Gie Kim, Sang-Yoon Park) SGOG-KGOG history and future cooperation (Jae-Weon Kim) SGOG SUNNY: data management, e-CRF (Zi-Yong Xiang) SGOG SUNNY: randomization (Wei Zhang) KGOG data management (Kidong Kim)

CRF, clinical report form; FIGO, International Federation of Gynecology and Obstetrics; KGOG, Korean Gynecologic Oncology Group; PET-CT, positron emission tomography-computed tomography; PR, progesterone receptor; SGOG, Shanghai Gynecologic Oncology Group; SUNNY, study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer.

^*Young doctors from KGOG.